Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery for gastric carcinoma at high risk of peritoneal carcinomatosis: short and long-term outcomes (GOETH STUDY)—a collaborative randomized controlled trial by ACOI, FONDAZIONE AIOM, SIC, SICE, and SICO

Trials

Study Protocol

G. Melotti¹  L. Bonavina²  S. Garattini³  V. Torri³  M. De Luca³  Eliana Rulli³  C. Gerardi³  Erica Rulli³  F. Santullo⁴  C. Abatini⁴  A. Di Giorgio⁴  F. Pacelli⁴ 

[1] Associazione Chirurghi Ospedalieri Italiani, ACOI, Rome, Italy;Division of General and Foregut Surgery, Department of Biomedical Sciences for Health, IRCCS Policlinico San Donato and University of Milan, Milan, Italy;Istituto Di Ricerche Farmacologiche “Mario Negri” IRCCS, Milan, Italy;Operational Unit of Peritoneum and Retroperitoneum Surgery, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo A. Gemelli, 8, 00168, Rome, Italy;

关键词: Gastric cancer;    Prophylactic surgery;    HIPEC CO;    Hyperthermic intraperitoneal chemotherapy;    Mitomycin;    Cisplatin;   

DOI  :  10.1186/s13063-022-06880-y

 received in 2022-02-24, accepted in 2022-11-02,  发布年份 2022

来源: Springer

【 授权许可】

CC BY   
© The Author(s) 2022

【 图 表 】

Fig. 1

40249_2022_1045_Article_IEq13.gif